ChemoCentryx’s Avacopan May Need Another Trial After Tepid Advisory Committee Vote

 
• By Sarah Karlin-Smith
  
ChemoCentryx’s avacopan may need a second Phase III trial to get FDA approval.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers